AMERICAN ORIENTL BIO (NYSE:AOB)
The Company, together with its wholly owned subsidiaries, is a pharmaceutical and Traditional Chinese Medicine company which develops, manufactures and commercializes both plant-based pharmaceutical and plant-based nutraceutical products.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
ReaperKK
(< 20)
Submitted: 2/13/2012 10:58:56 AM :
Start Price:
$0.83
AOB Score:
-0.19
The stock will be de-listed if it doesn't post an average close price of over $1.00 for 30 days. The deadline is March 21st, 2012 so it could push the price up artificially.
Recs
FUDweiser
(< 20)
Submitted: 2/12/2012 10:47:17 PM :
Start Price:
$0.86
AOB Score:
+3.54
Because this was Bill Mann's suggestion in hidden (or say rotten) gems service.
Recs
BuffettJunior1
(95.04)
Submitted: 11/14/2011 12:09:30 PM :
Start Price:
$0.74
AOB Score:
-4.54
99.99 percent of Chinese RTO's are frauds. I'm being conservative when I say 99.99 percent, its most likely 100 percent. The only thing these companies are good at is extracting cash from American investors.
Here is a great article published on gurufocus.com about Chinese RTO's:
http://www.gurufocus.com/news/130207/confessions-of-a-chinese-rto-investor
Recs
tomfoolme
(21.02)
Submitted: 10/6/2011 1:50:16 AM :
Start Price:
$0.57
AOB Score:
+27.22
china healthcare products
no div
Total Debt / Equity 0.28
Price Earnings 2.90
Price/Sales 0.14 <<<<<
Price/Book 0.09 <<<<
Price/Cash Flow 1.60
Recs
highwaym
(< 20)
Submitted: 8/1/2011 4:59:16 PM :
Start Price:
$1.17
AOB Score:
-34.98
Profitable, Pharmaceutical AND Traditional Chinese Medicine, looks cheap to me, in at 1.18
Recs
TheResurrection
(89.10)
Submitted: 7/13/2011 5:30:16 PM :
Start Price:
$1.21
AOB Score:
+33.83
ug-ly.
Recs
pbk100
(33.83)
Submitted: 6/1/2011 12:39:15 AM :
Start Price:
$1.25
AOB Score:
-34.25
Extremely cheap.
Recs
penywise
(80.35)
Submitted: 5/28/2011 10:16:05 AM :
Start Price:
$1.25
AOB Score:
-34.05
Down so long that it looks like up to me.
Don't get me wrong - I don't think there is a great long term investment thesis on this one, but at some point the ugliness in the Chinese small cap market has to stop - and when it does, a profitable small company with a clean balance sheet should be worth something. If this stock goes up 10 cents it will beat the market over the next year in terms of a percentage move.
Recs
NewFoolFan
(82.32)
Submitted: 5/23/2011 10:52:01 AM :
Start Price:
$1.30
AOB Score:
-38.70
Price/earnings and Debt/equity ratio. I think this stock is undervalued
Recs
TheGMaster
(96.35)
Submitted: 4/30/2011 9:04:44 AM :
Start Price:
$4.70
AOB Score:
-162.43
As you can see, I made the wrong call on AOB, which at one time was a Motley Fool Million Dollar Portfolio (MDP) holding. MDP impressively sold it 2-3 years ago before it tanked, but I unfortunately did not follow them with this move. On a positive note, this has been a very small investment for me (less than 0.5% of my portfolio). Where does it stand now? AOB is still making a profit, although a much smaller profit than in the past. In an effort to increase profitability, it appears that AOB's management has been shuffling the product portfolio to eliminate some high pharmaceutical ingredient costs and to work around some of the China Government's regulations. If they are successful, the stock price could rebound dramatically. I am willing to take a speculative gamble with an amount equivalent to 1/2 of my original investment. I can buy twice as many shares with 1/2 the original amount. If it tanks from here and I lose all of the money invested in AOB, that will be OK. This amount is not enough to lose any sleep over. I made a similar speculative bet with Sirius Sattelite radio when it was $0.12 per share that worked out nicely. I am mostly a dividend focused investor but a little speculation makes it interesting!
Recs
paola145
(28.55)
Submitted: 4/16/2011 9:45:40 PM :
Start Price:
$1.53
AOB Score:
-49.42
The CEO accompanied Premier Hu to the USA. If their CEO is on positive terms with the premier, AOB should have no trouble with unpredictable government moves. Also, the book value of this stock appears to be 25 times its price.
Recs
ChinaRTO
(99.77)
Submitted: 4/14/2011 3:17:34 AM :
Start Price:
$1.55
AOB Score:
+50.03
This is a tracking portfolio of all CAPS-ratable tickers in the Chinese RTO/SPAC space (i.e., companies that listed without filing an IPO).
American Oriental Bioengineering, Inc. went public via a reverse merger in 2002. The company is based in China.
Recs
medsmall
(20.33)
Submitted: 4/4/2011 10:59:16 PM :
Start Price:
$1.44
AOB Score:
-44.15
Price/earnings of 6.41, Price/book of 0.27, Debt/equity ratio of 0.29, pharmaceutical and healthcare products in China.
Recs
Recs
AllYouCanEatBuff
(69.24)
Submitted: 3/28/2011 11:51:52 AM :
Start Price:
$1.62
AOB Score:
-51.76
At this price, stock is way undervalued. They have some of the best recognized medical brands in China. However, they lack pricing power due to new govt reforms, and have shown that they have trouble allocating capital (constructing an expensive headquarters that decreased margins significantly). Despite this, strong brand in a growing economy and a booming middle class with disposable income = profitable company.
Recs
GoNuke
(20.88)
Submitted: 3/25/2011 2:13:29 AM :
Start Price:
$1.60
AOB Score:
+51.28
Chinese firms are not governed by financial reporting rules or good governance standards. It is a fundamentally flawed notion that one can be a minority shareholder in a Chinese company. The financial reports cannot be trusted, nor can management. Unless you have a personal connection with the owner managers chances are money invested in Chinese firms will be lost and you will never find out why.
Recs
Clément
(< 20)
Submitted: 3/18/2011 12:38:27 PM :
Start Price:
$1.73
AOB Score:
-57.66
Adding 20.5¢ for research and developpement, earning per share becomes > 42.5¢ for a return of more than 24 % !
Recs
cnbcgb
(56.94)
Submitted: 2/14/2011 5:41:34 PM :
Start Price:
$2.32
AOB Score:
-66.00
Because it is valued as if it couldn't possibly grow, even though they are well into R&D spending that should yield results.
Recs
Recs
gilboy7
(< 20)
Submitted: 2/3/2011 1:18:16 PM :
Start Price:
$2.32
AOB Score:
-68.04
I believe the Market is undervalueing AOB's shares at .4 book value and expect an upswing from here. AOB is one of China's top drug companies. They have a stabilizing cost of revenue down from 26% over the last few years to 6%. Management is investing more in R&D than in the past and allocatig less capital to purchasing other businesses to gow market share. Government regulations play a part in keeping revenues down. Products such as Jinji Capsules and Boke nasal spray both won awards as China's top branded drugs in 2009. Read: http://seekingalpha.com/article/243664-is-american-oriental-bioengineering-s-business-model-sound?source=yahoo , for more detailed analisys on AOB.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 422 : 1 2 3 4 5 6 7 8 9 10 Next »